The aims of this study were: 1. To examine the prevalence of risk factors and the risk of mortality from malignant tumors and lung cancer in 45–59-year-old Kaunas men; 2. To assess time trends during the period 1971–2000 in mortality from malignant tumors and lung cancer in Kaunas men aged 25–64 years. The random samples of Kaunas men aged 45–59 years from the Kaunas Rotterdam Intervention Study (1972–1974) and Study of Multifactorial Prevention of IHD (1977–1980) surveys (n=6446) were examined using the standard epidemiological methods. The participants of the two surveys were followed-up, in terms of the end points reached, from the beginning of each study until January 1, 2001. A multivariate Cox model was used for the analysis. The risk...
Aging population and the increasing exposure to carcinogens contribute to the rise of the global can...
Abstract Background This study aimed to assess the trends in the prevalence and levels of risk facto...
Trends in age-standardised mortality for all cancers and 21 cancers or groups of cancers over the pe...
Nation-al Cancer Registry indicated a gradual increase in the incidence of malignant tumours among m...
Objective. The aim of this study was to investigate time trends of lung cancer incidence by histolog...
Background: A decrease in lung cancer mortality among females below 50 years of age has been reporte...
An analysis of changes in mortality from major cancer sites and all cancer sites combined in 6 centr...
The paper aims to analyse the trends in mortality of men and women aged 65 and more in the Lodz regi...
Abstract Background Lung cancer (LC) is the leading cause of cancer deaths in men and the second mos...
An analysis of changes in mortality from major cancer sites and all cancer sites combined in 6 centr...
An analysis of changes in mortality from major cancer sites and all cancer sites combined in 6 centr...
An analysis of changes in mortality from major cancer sites and all cancer sites combined in 6 centr...
An analysis of changes in mortality from major cancer sites and all cancer sites combined in 6 centr...
Trends in age-standardised mortality for all cancers and 21 cancers or groups of cancers over the pe...
An analysis of changes in mortality from major cancer sites and all cancer sites combined in 6 centr...
Aging population and the increasing exposure to carcinogens contribute to the rise of the global can...
Abstract Background This study aimed to assess the trends in the prevalence and levels of risk facto...
Trends in age-standardised mortality for all cancers and 21 cancers or groups of cancers over the pe...
Nation-al Cancer Registry indicated a gradual increase in the incidence of malignant tumours among m...
Objective. The aim of this study was to investigate time trends of lung cancer incidence by histolog...
Background: A decrease in lung cancer mortality among females below 50 years of age has been reporte...
An analysis of changes in mortality from major cancer sites and all cancer sites combined in 6 centr...
The paper aims to analyse the trends in mortality of men and women aged 65 and more in the Lodz regi...
Abstract Background Lung cancer (LC) is the leading cause of cancer deaths in men and the second mos...
An analysis of changes in mortality from major cancer sites and all cancer sites combined in 6 centr...
An analysis of changes in mortality from major cancer sites and all cancer sites combined in 6 centr...
An analysis of changes in mortality from major cancer sites and all cancer sites combined in 6 centr...
An analysis of changes in mortality from major cancer sites and all cancer sites combined in 6 centr...
Trends in age-standardised mortality for all cancers and 21 cancers or groups of cancers over the pe...
An analysis of changes in mortality from major cancer sites and all cancer sites combined in 6 centr...
Aging population and the increasing exposure to carcinogens contribute to the rise of the global can...
Abstract Background This study aimed to assess the trends in the prevalence and levels of risk facto...
Trends in age-standardised mortality for all cancers and 21 cancers or groups of cancers over the pe...